Centre for Therapeutic Innovation
Melbourne’s Monash University is the first academic institution outside the United States to join Pfizer’s network of research partners under the Pfizer Centers for Therapeutic Innovation (CTI).
The CTI brings together leading academic medical centres and disease foundations, along with Pfizer scientists, with the aim of translating promising science into clinical candidates.
Under the CTI initiative Pfizer has also formed a partnership with the University of Queensland (UQ) to advance drug discovery in Australia. The agreement with UniQuest, UQ’s commercialisation arm offers new opportunities to develop effective treatments for challenging medical conditions that affect people around the world.